FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Corepharma Pyridostigmine Bromide Tablets Recall

Pyridostigmine Bromide Tablets USP, 60 mg, 100 count bottle, Rx only, Manufactured and…

Corepharma LLC · Middlesex, NJ

Risk level
Class II
Reported by FDA
Feb 12, 2014
Recall ID
D-1079-2014
Check your lot numberHow we source this data

Summary

Corepharma recalled Pyridostigmine Bromide Tablets starting Dec 13, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1079-2014 on Feb 12, 2014. Reason: Failed Dissolution Specification: Corepharma Inc. is recalling Pyridostigmine Bromide Tablets USP 60 mg due to an out of specification dissolution test generated at the 30 month stability time point. Status: Terminated.

Why it was recalled

Failed Dissolution Specification: Corepharma Inc. is recalling Pyridostigmine Bromide Tablets USP 60 mg due to an out of specification dissolution test generated at the 30 month stability time point.

Product description

Pyridostigmine Bromide Tablets USP, 60 mg, 100 count bottle, Rx only, Manufactured and Distributed by: Corepharma, LLC Middlesex, NJ 08846, NDC 64720-128-10

Lot numbers, UPCs & expiration codes

Lot #s and Exp dates: 106019 exp December-13 106020 exp December -13 106336 exp January-14 106337 exp January-14 106338 exp January-14 106097 exp February-14 106098 exp February-14 106099 exp February-14 106100 exp April-14 106545 exp April-14 106664 exp April-14 107208 exp July-14 107363 exp October-14 107574 exp October-14 107629 exp October-14 108167 exp February-15 108168 exp February-15 108169 exp February-15 108322 exp May-15

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1079-2014
Classification
Class II
Status
Terminated
Recall initiated
Dec 13, 2013
FDA report date
Feb 12, 2014
Quantity
174,888 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Corepharma LLC

Original FDA data

Every field from FDA enforcement report D-1079-2014, exactly as published.

Show all FDA fields
City
Middlesex
State
NJ
Status
Terminated
Country
United States
Event ID
67291
Address
215 Wood Ave
Code information
Lot #s and Exp dates: 106019 exp December-13 106020 exp December -13 106336 exp January-14 106337 exp January-14 106338 exp January-14 106097 exp February-14 106098 exp February-14 106099 exp February-14 106100 exp April-14 106545 exp April-14 106664 exp April-14 107208 exp July-14 107363 exp October-14 107574 exp October-14 107629 exp October-14 108167 exp February-15 108168 exp February-15 108169 exp February-15 108322 exp May-15
Postal code
08846-2554
Report date
Feb 12, 2014
Product type
Drugs
Recall number
D-1079-2014
Classification
Class II
Recalling firm
Corepharma LLC
Product quantity
174,888 Bottles
Termination date
Jan 29, 2015
Reason for recall
Failed Dissolution Specification: Corepharma Inc. is recalling Pyridostigmine Bromide Tablets USP 60 mg due to an out of specification dissolution test generated at the 30 month stability time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pyridostigmine Bromide Tablets USP, 60 mg, 100 count bottle, Rx only, Manufactured and Distributed by: Corepharma, LLC Middlesex, NJ 08846, NDC 64720-128-10
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Dec 13, 2013
Initial firm notification
Letter
Center classification date
Feb 5, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1079-2014, published Feb 12, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls